Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Aurora, CO
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Hollywood, FL
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Hollywood, FL
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Jacksonville, FL
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Longwood, FL
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Longwood, FL
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Ponte Vedra, FL
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Ponte Vedra, FL
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Lawrenceville, GA
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Roswell, GA
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Roswell, GA
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Chicago, IL
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Crystal Lake, IL
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Crystal Lake, IL
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Evansville, IN
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Evansville, IN
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Greenfield, IN
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Greenfield, IN
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Des Moines, IA
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Slidell, LA
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Slidell, LA
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Greenbelt, MD
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Greenbelt, MD
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Brockton, MA
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Brockton, MA
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Southfield, MI
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Southfield, MI
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Troy, MI
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Troy, MI
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Minneapolis, MN
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Biloxi, MS
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Biloxi, MS
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
St. Louis, MO
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Billings, MT
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Billings, MT
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Brick, NJ
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Brick, NJ
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Mine Hill, NJ
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Mine Hill, NJ
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Brooklyn, NY
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
New York, NY
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
New York, NY
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Asheboro, NC
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Asheboro, NC
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Chapel Hill, NC
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Charlotte, NC
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Greensboro, NC
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Greensboro, NC
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Franklin, OH
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Franklin, OH
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Beaver, PA
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Beaver, PA
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Melrose Park, PA
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Melrose Park, PA
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Norristown, PA
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Norristown, PA
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Philadelphia, PA
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Peak, SC
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Peak, SC
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Desoto, TX
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Desoto, TX
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Killeen, TX
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Killeen, TX
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Sugar Land, TX
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
St. George, UT
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
St. George, UT
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Renton, WA
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Renton, WA
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Milwaukee, WI
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Novo Nordisk Clinical Trial Call Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated:  2/23/2016
mi
from
Calgary,
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
mi
from
Calgary,
Click here to add this to my saved trials
The Health Outcomes Management and Evaluation (HOME) Study
Improving Primary Care of Patients With Mental Disorders
Status: Enrolling
Updated:  2/25/2016
mi
from
Marietta, GA
The Health Outcomes Management and Evaluation (HOME) Study
Improving Primary Care of Patients With Mental Disorders
Status: Enrolling
Updated: 2/25/2016
Cobb County Community Service Board
mi
from
Marietta, GA
Click here to add this to my saved trials
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
The Effect of the Beta 2 Agonist, Formoterol, on Recovery From Hypoglycemia
Status: Enrolling
Updated:  2/26/2016
mi
from
New Haven, CT
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
The Effect of the Beta 2 Agonist, Formoterol, on Recovery From Hypoglycemia
Status: Enrolling
Updated: 2/26/2016
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant
A Double-Blind, Randomized, Placebo Controlled Intervention Study to Assess the Impact of Sitagliptin 100 mg/Day for 1 Year on Insulin Independence Following Pancreatectomy and Autoislet Transplantation
Status: Enrolling
Updated:  2/29/2016
mi
from
Minneapolis, MN
Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant
A Double-Blind, Randomized, Placebo Controlled Intervention Study to Assess the Impact of Sitagliptin 100 mg/Day for 1 Year on Insulin Independence Following Pancreatectomy and Autoislet Transplantation
Status: Enrolling
Updated: 2/29/2016
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated:  2/29/2016
mi
from
Minneapolis, MN
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Park Nicollet International Diabetes Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated:  2/29/2016
mi
from
New Haven, CT
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Eda Cengiz
mi
from
New Haven, CT
Click here to add this to my saved trials
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated:  2/29/2016
mi
from
Tallahassee, FL
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Larry Deeb
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated:  2/29/2016
mi
from
Detroit, MI
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Henry Ford
mi
from
Detroit, MI
Click here to add this to my saved trials
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated:  2/29/2016
mi
from
Ocean Springs, MS
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
The Diabetes Center
mi
from
Ocean Springs, MS
Click here to add this to my saved trials